DOI: 10.32098/mltj_2026_7527

Patient perspectives on PRP biological characterization: A French survey of amateur sports associations on awareness, perceived value, and quality control sensitivity on PRP injections

Authors

  • Alice Bitsch Regenerative Medicine Department of Excellence, Marseille, France
  • Jonathan Siboni Regenerative Medicine Department of Excellence, Marseille, France
  • Mathilde Grandvuillemin Regenerative Medicine Department of Excellence, Marseille, France
  • Zoé Bessonnet Regenerative Medicine Department of Excellence, Marseille, France
  • Marie-Alix Ferando Junior Phocéenne du Médicament, Faculty of Pharmacy, Aix-Marseille University, Marseille, France
  • Marina Galado Junior Phocéenne du Médicament, Faculty of Pharmacy, Aix-Marseille University, Marseille, France
  • Orso Cortinchi Junior Phocéenne du Médicament, Faculty of Pharmacy, Aix-Marseille University, Marseille, France
  • Florence Sabatier Regenerative Medicine Department of Excellence, Marseille, France; Cell Therapy Laboratory, Hôpital de la Conception, AP-HM, INSERM CIC BT 1409, Marseille, France; Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France
  • Jérémy Magalon Regenerative Medicine Department of Excellence, Marseille, France; Cell Therapy Laboratory, Hôpital de la Conception, AP-HM, INSERM CIC BT 1409, Marseille, France; Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France

jeremy.magalon@ap-hm.fr

Keywords

Platelet-rich plasma (PRP), characterization, quality control, survey, patient perspectives, regenerative medicine

Abstract

Background: Platelet-rich plasma (PRP) is increasingly used in orthopedics and sports medicine, but its biological characterization remains poorly standardized. While international guidelines recommend systematic reporting, patient perspectives on this issue are lacking. This study aimed to explore awareness, perceptions, and sensitivity of potential patients towards PRP injections and the biological characterization of PRP preparations.
Materials and methods: We conducted an anonymous online survey including 15 questions divided into three categories (demographic data, perspectives and knowledge about PRP, and PRP characterization and accessibility). Thirty-eight amateur sports associations in France were contacted, 13 of which distributed the questionnaire to their members.
Results: A total of 267 valid responses were collected and analyzed. PRP injections were poorly known, with 64% of respondents having never heard about PRP and only 7% having previously received an injection. Despite this limited awareness, 69% expressed definite or possible interest in PRP treatment. Two-thirds (66%) considered knowledge of biological composition important, and nearly half (46%) indicated they would be willing to pay extra for quality-controlled PRP.
Conclusions: This study highlights the need for better patient education and clarity in PRP characterization and emphasizes that standardizing quality control and improving communication could increase its credibility, strengthen patient trust, and support its clinical adoption.

View the entire article

Downloads

References

  1. Laver L, Filardo G, Sanchez M, Magalon J, Tischer T, Abat F, et al. The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma). Knee Surg Sports Traumatol Arthrosc. 2024;32(4):783-97. doi: 10.1002/ksa.12077.
  2. Kon E, de Girolamo L, Laver L, Andriolo L, Andia I, Bastos R, et al. Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Knee Surg Sports Traumatol Arthrosc. 2024;32(11):2938-49. doi: 10.1002/ksa.12320.
  3. Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells. J Bone Joint Surg Am. 2017;99(10):809-19. doi: 10.2106/JBJS.16.00793.
  4. Chu CR, Rodeo S, Bhutani N, Goodrich LR, Huard J, Irrgang J, et al. Optimizing clinical use of biologics in orthopaedic surgery: Consensus recommendations from the 2018 AAOS/NIH U-13 conference. J Am Acad Orthop Surg. 2019;27(2):e50-e63. doi: 10.5435/JAAOS-D-18-00305.
  5. Finnoff JT, Awan TM, Borg-Stein J, Harmon KG, Herman DC, Malanga GA, et al. American Medical Society for Sports Medicine Position Statement: Principles for the responsible use of regenerative medicine in sports medicine. Clin J Sport Med. 2021;31(6):530-41. doi: 10.1097/JSM.0000000000000973.
  6. Magalon J, Brandin T, Francois P, Degioanni C, De Maria L, Grimaud F, et al. Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine. Platelets. 2021;32(2):200-8. doi: 10.1080/09537104.2020.1832653.
  7. Fadadu PP, Mazzola AJ, Hunter CW, Davis TT. Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: a call for PRP standardization. Reg Anesth Pain Med. 2019;44(6):652-9. doi: 10.1136/rapm-2018-100356.
  8. Stone AV, Abed V, Owens M, Brunty N, Skinner M, Jacobs C. Randomized controlled trials on platelet-rich plasma for knee osteoarthritis poorly adhere to the Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO) guidelines: A systematic review. Am J Sports Med. 2024;52(6):1617-23. doi: 10.1177/03635465231185289.
  9. Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004 Sep 29;6(3):e34. doi: 10.2196/jmir.6.3.e34. Erratum in: doi: 10.2196/jmir.2042.
  10. Noback PC, Donnelley CA, Yeatts NC, Parisien RL, Fleischli JE, Ahmad CS, et al. Utilization of orthobiologics by sports medicine physicians: A survey-based study. J Am Acad Orthop Surg Glob Res Rev. 2021;5(1):e20.00185. doi: 10.5435/JAAOSGlobal-D-20-00185.
  11. Hurley ET, Sherman SL, Stokes DJ, Rodeo SA, Shapiro SA, Mautner K, et al. Experts achieve consensus on a majority of statements regarding platelet-rich plasma treatments for treatment of musculoskeletal pathology. Arthroscopy. 2024;40(2):470-477.e1. doi: 10.1016/j.arthro.2023.08.020.

Published

2026-09-15

How to Cite

1.
Bitsch A, Siboni J, Grandvuillemin M, Bessonnet Z, Ferando M-A, Galado M, et al. Patient perspectives on PRP biological characterization: A French survey of amateur sports associations on awareness, perceived value, and quality control sensitivity on PRP injections. MLTJ [Internet]. 2026 Sep. 15 [cited 2026 Nov. 19];16. Available from: https://mltj.online/index.php/mltj/article/view/7527